270 related articles for article (PubMed ID: 31383698)
1. Pregnancy outcome among HIV-infected women on different antiretroviral therapies in Ethiopia: a cohort study.
Ejigu Y; Magnus JH; Sundby J; Magnus MC
BMJ Open; 2019 Aug; 9(8):e027344. PubMed ID: 31383698
[TBL] [Abstract][Full Text] [Related]
2. Birth outcomes in South African women receiving highly active antiretroviral therapy: a retrospective observational study.
van der Merwe K; Hoffman R; Black V; Chersich M; Coovadia A; Rees H
J Int AIDS Soc; 2011 Aug; 14():42. PubMed ID: 21843356
[TBL] [Abstract][Full Text] [Related]
3. Maternal antiretroviral drugs during pregnancy and infant low birth weight and preterm birth.
Szyld EG; Warley EM; Freimanis L; Gonin R; Cahn PE; Calvet GA; Duarte G; Melo VH; Read JS;
AIDS; 2006 Nov; 20(18):2345-53. PubMed ID: 17117021
[TBL] [Abstract][Full Text] [Related]
4. Antiretroviral therapy use during pregnancy and adverse birth outcomes in South African women.
Malaba TR; Phillips T; Le Roux S; Brittain K; Zerbe A; Petro G; Ronan A; McIntyre JA; Abrams EJ; Myer L
Int J Epidemiol; 2017 Oct; 46(5):1678-1689. PubMed ID: 29040569
[TBL] [Abstract][Full Text] [Related]
5. Comparative Safety of Antiretroviral Treatment Regimens in Pregnancy.
Zash R; Jacobson DL; Diseko M; Mayondi G; Mmalane M; Essex M; Petlo C; Lockman S; Makhema J; Shapiro RL
JAMA Pediatr; 2017 Oct; 171(10):e172222. PubMed ID: 28783807
[TBL] [Abstract][Full Text] [Related]
6. Declines in low birth weight and preterm birth among infants who were born to HIV-infected women during an era of increased use of maternal antiretroviral drugs: Pediatric Spectrum of HIV Disease, 1989-2004.
Schulte J; Dominguez K; Sukalac T; Bohannon B; Fowler MG;
Pediatrics; 2007 Apr; 119(4):e900-6. PubMed ID: 17353299
[TBL] [Abstract][Full Text] [Related]
7. Effect of highly active antiretroviral treatment (HAART) during pregnancy on pregnancy outcomes: experiences from a PMTCT program in western India.
Darak S; Darak T; Kulkarni S; Kulkarni V; Parchure R; Hutter I; Janssen F
AIDS Patient Care STDS; 2013 Mar; 27(3):163-70. PubMed ID: 23477457
[TBL] [Abstract][Full Text] [Related]
8. The effect of maternal HIV status and treatment duration on body composition of HIV-exposed and HIV-unexposed preterm, very and extremely low-birthweight infants.
Strydom K; Nel DG; Dhansay MA; Van Niekerk E
Paediatr Int Child Health; 2018 Aug; 38(3):163-174. PubMed ID: 29790827
[TBL] [Abstract][Full Text] [Related]
9. Effect of antiretroviral therapy on pregnancy outcome in HIV-1 positive women.
Kowalska A; Niemiec T; El Midaoui A; Burkacka E
Med Wieku Rozwoj; 2003; 7(4 Pt 1):459-68. PubMed ID: 15010556
[TBL] [Abstract][Full Text] [Related]
10. Association between HIV antiretroviral therapy and preterm birth based on antenatal ultrasound gestational age determination: a comparative analysis.
Venkatesh KK; Farhad M; Fenton T; Moodley D; Naik S; Nakabiito C; Fairlie L; Fowler MG; Stringer JSA; Chi BH
AIDS; 2019 Dec; 33(15):2403-2413. PubMed ID: 31764105
[TBL] [Abstract][Full Text] [Related]
11. Perinatal outcomes associated with maternal HIV and antiretroviral therapy in pregnancies with accurate gestational age in South Africa.
Santosa WB; Staines-Urias E; Tshivuila-Matala COO; Norris SA; Hemelaar J
AIDS; 2019 Aug; 33(10):1623-1633. PubMed ID: 30932959
[TBL] [Abstract][Full Text] [Related]
12. [Prevalence and associated risk factors on preterm birth, low birth weight, and small for gestational age among HIV-infected pregnant women in Hunan province, 2011-2017].
Li HX; Zheng JF; Huang GW; Xiao J; Wang H; Yang M; Feng N
Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Oct; 39(10):1368-1374. PubMed ID: 30453439
[No Abstract] [Full Text] [Related]
13. Comparative safety of dolutegravir-based or efavirenz-based antiretroviral treatment started during pregnancy in Botswana: an observational study.
Zash R; Jacobson DL; Diseko M; Mayondi G; Mmalane M; Essex M; Gaolethe T; Petlo C; Lockman S; Holmes LB; Makhema J; Shapiro RL
Lancet Glob Health; 2018 Jul; 6(7):e804-e810. PubMed ID: 29880310
[TBL] [Abstract][Full Text] [Related]
14. Pregnancy outcome among HIV positive women receiving antenatal HAART versus untreated maternal HIV infection.
Joseph O; Biodun O; Michael E
J Coll Physicians Surg Pak; 2011 Jun; 21(6):356-9. PubMed ID: 21711992
[TBL] [Abstract][Full Text] [Related]
15. Risk of preeclampsia in HIV-positive pregnant women receiving HAART: a matched cohort study.
Boyajian T; Shah PS; Murphy KE
J Obstet Gynaecol Can; 2012 Feb; 34(2):136-141. PubMed ID: 22340062
[TBL] [Abstract][Full Text] [Related]
16. Adverse effects in children exposed to maternal HIV and antiretroviral therapy during pregnancy in Brazil: a cohort study.
Delicio AM; Lajos GJ; Amaral E; Cavichiolli F; Polydoro M; Milanez H
Reprod Health; 2018 May; 15(1):76. PubMed ID: 29747664
[TBL] [Abstract][Full Text] [Related]
17. Antiretroviral therapy during pregnancy and risk of preterm birth.
Gagnon LH; MacGillivray J; Urquia ML; Caprara D; Murphy KE; Yudin MH
Eur J Obstet Gynecol Reprod Biol; 2016 Jun; 201():51-5. PubMed ID: 27060543
[TBL] [Abstract][Full Text] [Related]
18. Maternal HIV infection and risk of adverse pregnancy outcomes in Hunan province, China: A prospective cohort study.
Li H; Liu J; Tan D; Huang G; Zheng J; Xiao J; Wang H; Huang Q; Feng N; Zhang G
Medicine (Baltimore); 2020 Feb; 99(8):e19213. PubMed ID: 32080112
[TBL] [Abstract][Full Text] [Related]
19. Altered angiogenesis as a common mechanism underlying preterm birth, small for gestational age, and stillbirth in women living with HIV.
Conroy AL; McDonald CR; Gamble JL; Olwoch P; Natureeba P; Cohan D; Kamya MR; Havlir DV; Dorsey G; Kain KC
Am J Obstet Gynecol; 2017 Dec; 217(6):684.e1-684.e17. PubMed ID: 29031892
[TBL] [Abstract][Full Text] [Related]
20. Antiretroviral therapy in pregnancy: balancing the risk of preterm delivery with prevention of mother-to-child HIV transmission.
Townsend CL; Tookey PA; Newell ML; Cortina-Borja M
Antivir Ther; 2010; 15(5):775-83. PubMed ID: 20710059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
